Volume 10, Number 1, January 2004

Human Infection with M- Strain of Brucella canis

Jorge C. Wallach,*† Guillermo H. Giambartolomei,† Pablo C. Baldi,† and Carlos A. Fossati†‡
*Hospital F. J. Muñiz, Buenos Aires, Argentina; †IDEHU, Universidad de Buenos Aires, Buenos Aires, Argentina; and ‡Universidad Nacional de La Plata, La Plata, Argentina

Figure. Serologic follow-up of a human infection by Brucella canis M-. CP, cytoplasmic proteins; BLS, Brucella lumazine synthase; HS, B. canis hot-saline extract. The enzyme-linked immunosorbent assay (ELISA) titer was calculated as the inverse of the last serum dilution that yielded an optical density higher than the cut-off of the assay.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed December 22, 2003

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention